Addex Therapeutics (ADXN) Operating Leases (2018 - 2026)
Addex Therapeutics (ADXN) posted Operating Leases of $31960.9 for Q1 2026, down 5.42% sequentially from $33791.6 in Q4 2025, and down 12.4% YoY from $36486.3 in Q1 2025.
Addex Therapeutics (ADXN) Operating Leases (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Operating Leases for 9 years, with the latest figure at $31960.9 in Q1 2026.
- Quarterly Operating Leases fell 12.4% year-over-year to $31960.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31960.9 (down 12.4% YoY) and the FY2025 annual result came in at $32575.1, down 31.76% from the prior year.
- Operating Leases slipped to $31960.9 in Q1 2026 per ADXN's latest filing, from $33791.6 in the prior quarter.
- Over five years, Operating Leases peaked at $388188.7 in Q4 2023 and troughed at $21883.7 in Q2 2024.
- A 5-year average of $99585.0 and a median of $39280.8 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases sank 87.65% in 2024, then soared 70.53% in 2025.
- Over 5 years, Operating Leases stood at $387322.3 in 2022, then grew by 0.22% to $388188.7 in 2023, then tumbled by 87.65% to $47937.1 in 2024, then dropped by 29.51% to $33791.6 in 2025, then decreased by 5.42% to $31960.9 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $31960.9, $33791.6, and $36208.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,960.87 |
| Dec 31, 2025 | 33,791.59 |
| Sep 30, 2025 | 36,208.17 |
| Jun 30, 2025 | 37,318.98 |
| Mar 31, 2025 | 36,486.27 |
| Dec 31, 2024 | 47,937.07 |
| Sep 30, 2024 | 42,188.58 |
| Jun 30, 2024 | 21,883.65 |
| Mar 31, 2024 | 26,288.83 |
| Dec 31, 2023 | 388,188.73 |
| Sep 30, 2023 | 132,350.90 |
| Jun 30, 2023 | 36,295.85 |
| Mar 31, 2023 | 39,280.80 |
| Dec 31, 2022 | 387,322.31 |
| Sep 30, 2022 | 166,899.04 |
| Jun 30, 2022 | 97,775.01 |
| Mar 31, 2022 | 130,768.60 |
| Dec 31, 2021 | 522,745.19 |
| Sep 30, 2021 | 250,754.55 |
| Jun 30, 2021 | 177,094.25 |